MicroRNAs: Key players in carcinogenesis and novel therapeutic targets

被引：108
|
作者：
Mirnezami, A. H. F. [1 ]
Pickard, K. [2 ]
Zhang, L. [2 ]
Primrose, J. N. [1 ]
Packham, G. [2 ]
机构：
[1] Southampton Gen Hosp, Level F Ctr Block, Univ Surg Unit, Southampton SO16 6YD, Hants, England
[2] Univ Southampton, Canc Sci Div, Southampton, Hants, England
来源：
EJSO | 2009年 / 35卷 / 04期
关键词：
MicroRNA; Molecular profiling; Cancer; Clinical utility; HUMAN LUNG CANCERS; GENE-EXPRESSION; BREAST-CANCER; SMALL RNAS; ANTISENSE OLIGONUCLEOTIDES; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; IN-VIVO; PROSTATE; GROWTH;
D O I：
10.1016/j.ejso.2008.06.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MicroRNAs (miRNAs) represent a recently uncovered class of small and endogenous non-coding RNAs. MiRNA function is critical to normal cellular processes such as differentiation and apoptosis, and recent studies have demonstrated that deregulated miRNA expression contributes to the malignant phenotype. The purpose of this review is to summarise these findings in relation to the most common human malignancies, and to analyse the clinical and therapeutic opportunities they provide. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：339 / 347
页数：9
相关论文
共 50 条
  • [41] MicroRNAs and exosomes: key players in HIV pathogenesis
    Nahand, J. Sadri
    Bokharaei-Salim, F.
    Karimzadeh, M.
    Moghoofei, M.
    Karampoor, S.
    Mirzaei, H. R.
    Tabibzadeh, A.
    Jafari, A.
    Ghaderi, A.
    Asemi, Z.
    Mirzaei, H.
    Hamblin, M. R.
    HIV MEDICINE, 2020, 21 (04) : 246 - 278
  • [42] MicroRNAs: key players of normal and malignant myelopoiesis
    Alemdehy, Mir Farshid
    Erkeland, Stefan J.
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (04) : 261 - 267
  • [43] Oncogenic MicroRNAs: Key Players in Malignant Transformation
    Frixa, Tania
    Donzelli, Sara
    Blandino, Giovanni
    CANCERS, 2015, 7 (04): : 2466 - 2485
  • [44] Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
    Andreadou, Ioanna
    Cabrera-Fuentes, Hector A.
    Devaux, Yvan
    Frangogiannis, Nikolaos G.
    Frantz, Stefan
    Guzik, Tomasz
    Liehn, Elisa A.
    Gomes, Clarissa P. C.
    Schulz, Rainer
    Hausenloy, Derek J.
    CARDIOVASCULAR RESEARCH, 2019, 115 (07) : 1117 - 1130
  • [45] MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis
    Izzotti, Alberto
    Cartiglia, Cristina
    Steele, Vernon E.
    De Flora, Silvio
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2012, 751 (02) : 287 - 303
  • [46] MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets
    Batkai, Sandor
    Thum, Thomas
    CURRENT HYPERTENSION REPORTS, 2012, 14 (01) : 79 - 87
  • [47] MicroRNAs as therapeutic targets in human cancers
    Shah, Maitri Y.
    Calin, George A.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2014, 5 (04) : 537 - 548
  • [48] microRNAs in asthma: potential therapeutic targets
    Greene, Catherine M.
    Gaughan, Kevin P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (01) : 66 - 72
  • [49] Strategies to use microRNAs as therapeutic targets
    Krutzfeldt, Jan
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (05) : 551 - 561
  • [50] MicroRNAs as therapeutic targets in human diseases
    Jeyaseelan, Kandiah
    Herath, Wishva B.
    Armugam, Arunmozhiarasi
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (08) : 1119 - 1129
12345